Pirfenidone, sold under the brand name Esbriet among others, is a medication used for the treatment of idiopathic pulmonary fibrosis. It works by reducing lung fibrosis through downregulation of the production of growth factors and procollagens I and II. It was first approved in Japan for the treatment of people with idiopathic pulmonary fibrosis after clinical trials in 2008.
Pirfenidone, sold under the brand name Esbriet among others, is a medication used for the treatment of idiopathic pulmonary fibrosis. It works by reducing lung fibrosis through downregulation of the production of growth factors and procollagens I and II. It was first approved in Japan for the treatment of people with idiopathic pulmonary fibrosis after clinical trials in 2008.
Source: Wikipedia "Pirfenidone" · CC BY-SA 4.0
Share this article: X · Bluesky